SCHEMBL5366288

SCHEMBL5366288

Cc1cc(N)cc(C(=O)O)c1Oc1c(F)cccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
PLG P00747 2/20 0.40
PLAU P00749 2/20 0.40
DHODH Q02127 3/20 0.39
ALB P02768 1/20 0.39
GCK P35557 1/20 0.38
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
NOTUM Q6P988 1/20 0.38
MYC P01106 1/20 0.36
THRB P10828 2/20 0.36
RECQL P46063 2/20 0.36
USP2 O75604 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5326571 0.78 KDM4E (0.52) KDM4EMEN1KMT2ATDP1ALDH1A1
SCHEMBL5364608 0.77 ALDH1A1 (0.45) KDM4EMEN1KMT2ATDP1PLAU
SCHEMBL14207284 0.71 KDM4E (0.55) KDM4EMEN1KMT2ATDP1ALDH1A1
SCHEMBL20045613 0.70 ALDH1A1 (0.46) KDM4EMEN1KMT2ATDP1ALDH1A1
SCHEMBL20045610 0.68 KDM4E (0.66) KDM4EMEN1KMT2ATDP1ALB
SCHEMBL5366292 0.68 GAA (0.48) KDM4EMEN1KMT2AGCKALDH1A1
SCHEMBL90325 0.67 KDM4E (0.70) KDM4EMEN1KMT2ATDP1ALDH1A1
SCHEMBL5424439 0.67 KDM4E (0.70) KDM4EMEN1KMT2ATDP1ALDH1A1
SCHEMBL29933044 0.66 ALB (0.55) KDM4EKMT2ATDP1ALBALDH1A1
SCHEMBL184046 0.66 ALB (0.55) KDM4EKMT2ATDP1ALBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663979-B1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS RAQUALIA PHARMA INC (JP) 2013-10-09 EP disclosed
US-7238714-B2 Aryl or heteroaryl amide compounds PFIZER JAPAN, INC. (JP) 2007-07-03 US disclosed
EP-1663979-A1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS PFIZER INC. (US) 2006-06-07 EP disclosed
US-20050065188-A1 Aryl or heteroaryl amide compounds ASKAT INC. (JP) 2005-03-24 US disclosed
WO-2005021508-A1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS PFIZER INC. (US) 2005-03-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065188-A1 Aryl or heteroaryl amide compounds HRH2, PTGER1, LTB4R2 KDM4E 875/4885MEN1 4236/4885KMT2A 1452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.